KR880006186A - 4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산 - Google Patents

4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산 Download PDF

Info

Publication number
KR880006186A
KR880006186A KR870012473A KR870012473A KR880006186A KR 880006186 A KR880006186 A KR 880006186A KR 870012473 A KR870012473 A KR 870012473A KR 870012473 A KR870012473 A KR 870012473A KR 880006186 A KR880006186 A KR 880006186A
Authority
KR
South Korea
Prior art keywords
lower alkyl
alkyl
hydroxy
compound
hydrogen
Prior art date
Application number
KR870012473A
Other languages
English (en)
Other versions
KR950005775B1 (ko
Inventor
제이. 크레그 로버트
엘. 렌쯔 넬슨
Original Assignee
게리 디. 스트리트
멜렐다우 파마슈티컬스 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 게리 디. 스트리트, 멜렐다우 파마슈티컬스 인코포레이티드 filed Critical 게리 디. 스트리트
Publication of KR880006186A publication Critical patent/KR880006186A/ko
Application granted granted Critical
Publication of KR950005775B1 publication Critical patent/KR950005775B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/55—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (8)

  1. 하기일반식(I)의 화합물.
    상기식에서, n은 0내지 2의 정수이고 R은 탄소원자수 6내지 15의 직쇄 알킬이고 x는 수소이거나, n이 1 또는 2인 경우, x는 -NH2일수 있고, Y는 하이드록시, -0-(저급알킬), -NH2-NH(저급알킬), -N-(저급알킬)2또는(여기에서는 R'는 수소, 탄소원자수 1내지 4의 알킬 또는 벤질이다)이며, Z는 하이드록시, -O-(저급알킬), -HN2-NH-(저급알킬)또는 N-(저급알킬)2이다.
  2. 제1항에 있어서, 하기 일반식의 화합물.`
    상기식에서, n은 0내지 2의 정수이고 R은 탄소원자수 6내지 15의 직쇄 알킬이고 X는 수소이거나, n이 1 또는 2인 경우, X는 -NH2일수 있고, Y는 하이드록시, -0-(저급알킬), -NH2-NH(저급알킬), -N-(저급알킬)2또는(여기에서는 R'는 수소, 탄소원자수 1내지 4의 알킬 또는 벤질이다)이며; Z는 하이드록시, -O-(저급알킬), -HN2-NH-(저급알킬)또는 N-(저급알킬)2이다.
  3. 제1항에 있어서, 하기 일반식의 화합물.`
    상기식에서, n은 0내지 2의 정수이고; R은 탄소원자수 6내지 15의 직쇄 알킬이고; Y"는 하이드록시, -NH2-NH(저급알킬), -N-(저급알킬)2또는(여기에서는 R'는 수소, 탄소원자수 1내지 4의 알킬 또는 벤질이다)이다.
  4. 제1항에 있어서, [4(R)-[1X4β, 4(Z)]]-4-[1-[(카복시메틸)티오]-2-헥사데세닐]-4-하이드록시사이클로 헥산카복실산인 화합물.
  5. 제1항에 있어서, [1αX4β, 4(Z)]-4-[1-[(2-카복시메틸)티오]-2-헥사데세닐]-4-하이드록시사이클로 헥산카복실산인 화합물.
  6. 제1항에 있어서, [4(R)-[1α,4β, 4(Z)]-4-[1-[(2-카복시에틸)티오]-2-헥사데세닐-4-하이드록시사이클로헥산카복실산인 화합물.
  7. 제1항에 있어서, [1α,4β, 4(Z)]-4-[1-[(3-카복시프로필)티오]-2-헥사데세닐]-4-하이드록시사이클로헥산카복실산인 화합물.
  8. 일반식(I)의 에폭사이드를 적절한 용매중 염기 존재하에 일반식(Ⅱ)의 멀캅토알카노산 유도체와 반응시키고, 임의로 Y', Y" 또는 Z'가 -O-(저급알킬)인 경우 강한 무기 염기로 처리하고 강산으로 산성화시켜 Y', Y"또는 Z가-OH인 화합물을 제조함을 특징으로 하여 일반식(I)의 화합물을 제조하는 방법.
    상기식에서, n은 0내지 2의 정수이고; R은 탄소원자수 6내지 15의 직쇄 알킬이고; X는 수소이거나, n은 1 또는 2인 경우, X는 -NH2일수 있고, Y는 하이드록시, -0-(저급알킬), -NH2-NH(저급알킬), 또는 -N-(저급알킬)2또는(여기어서 R'는 수소, 탄소원자 1내지 4의 알킬 또는 벤질이다)이며; Z는 하이드록시, -O-(저급알킬), -HN2-NH-(저급알킬), 또는 N-(저급알킬)2이고, X는 수소이거나, n이 1또는 2인 경우, -Q-NH-(여기서, Q는 아민 보호 그룹이다) 일 수 있으며, Y"는 -O-(저급알킬), -NH2, -NH(저급알킬),-N-(저급알킬)2또는(여기서, Y"는 -O-(저급알킬)이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870012473A 1986-11-07 1987-11-06 4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산 KR950005775B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/928,759 US4748274A (en) 1986-11-07 1986-11-07 4-hydroxy-4-(substituted alkenyl)cyclohexanecarboxylic acids
US928759 1986-11-07

Publications (2)

Publication Number Publication Date
KR880006186A true KR880006186A (ko) 1988-07-22
KR950005775B1 KR950005775B1 (ko) 1995-05-30

Family

ID=25456699

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870012473A KR950005775B1 (ko) 1986-11-07 1987-11-06 4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산

Country Status (21)

Country Link
US (1) US4748274A (ko)
EP (1) EP0270843B1 (ko)
JP (1) JPH07113011B2 (ko)
KR (1) KR950005775B1 (ko)
CN (1) CN1009088B (ko)
AT (1) ATE61352T1 (ko)
AU (1) AU595397B2 (ko)
CA (1) CA1296740C (ko)
DE (1) DE3768449D1 (ko)
DK (1) DK583887A (ko)
ES (1) ES2036561T3 (ko)
FI (1) FI87923C (ko)
GR (1) GR3002075T3 (ko)
HU (1) HU197880B (ko)
IE (1) IE872998L (ko)
IL (1) IL84364A (ko)
NO (1) NO167382C (ko)
NZ (1) NZ222427A (ko)
PH (1) PH24148A (ko)
PT (1) PT86093B (ko)
ZA (1) ZA878217B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102082304B1 (ko) 2013-05-02 2020-02-27 에스케이케미칼 주식회사 공중합 폴리에스테르 수지 및 이를 이용한 성형제품

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4622422A (en) * 1985-08-23 1986-11-11 Merrell Dow Pharmaceuticals Inc. Cyclohexanealkanoic acids

Also Published As

Publication number Publication date
NO874627L (no) 1988-05-09
FI874821A0 (fi) 1987-11-02
AU8060487A (en) 1988-07-28
US4748274A (en) 1988-05-31
ATE61352T1 (de) 1991-03-15
NO167382C (no) 1991-10-30
DK583887A (da) 1988-05-08
EP0270843A1 (en) 1988-06-15
GR3002075T3 (en) 1992-12-30
FI874821A (fi) 1988-05-08
AU595397B2 (en) 1990-03-29
IL84364A0 (en) 1988-04-29
FI87923C (fi) 1993-03-10
KR950005775B1 (ko) 1995-05-30
JPH07113011B2 (ja) 1995-12-06
PT86093B (pt) 1990-11-20
CA1296740C (en) 1992-03-03
NO167382B (no) 1991-07-22
NZ222427A (en) 1989-06-28
HU197880B (en) 1989-06-28
NO874627D0 (no) 1987-11-06
CN1009088B (zh) 1990-08-08
DK583887D0 (da) 1987-11-06
EP0270843B1 (en) 1991-03-06
ZA878217B (en) 1988-04-28
IE872998L (en) 1988-05-07
JPS63198660A (ja) 1988-08-17
IL84364A (en) 1991-08-16
DE3768449D1 (en) 1991-04-11
CN87107599A (zh) 1988-08-03
PT86093A (en) 1987-12-01
HUT45475A (en) 1988-07-28
PH24148A (en) 1990-03-22
FI87923B (fi) 1992-11-30
ES2036561T3 (es) 1993-06-01

Similar Documents

Publication Publication Date Title
PT99134A (pt) Processo para a preparacao de derivados da piperazina
KR960007592A (ko) 신규한 피롤로카바졸
KR880006186A (ko) 4-하이드록시-4-(치환된 알케닐)사이클로헥산 카복실산
ATE93861T1 (de) Synthese von beta-lactamverbindungen.
KR930702339A (ko) 에폭시숙시남산 유도체
NZ240404A (en) Oxysulphonyl (thio)carbamate derivatives and pharmaceutical
KR840006012A (ko) 포스페이트 유도체의 제조방법
DK19885A (da) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl (eller thienyl)-methyl-propylaminer, fremgangsmaade til fremstilling deraf, samt farmaceutiske midler indeholdende disse
KR870002068A (ko) 사이클로헥산 알카노산 및 그의 제조방법
KR840008012A (ko) 아미노에틸-피리딘 및 -피라진유도체의 제조방법
KR920002564A (ko) N-알킬 티아졸리딘 유도체
DE3361830D1 (en) 4-(substituted alkyl)-n-(1,3-dithiolan-2-ylidene) aniline
KR910000712A (ko) 이미다졸 유도체의 제조방법
KR840002374A (ko) 디옥산 진통제의 합성방법
KR840004758A (ko) 새로운 세펨화합물의 제조방법
GB1354405A (en) Crotonamide derivatives
KR890002177A (ko) 신규한 세펨 화합물
KR830007520A (ko) 펩타이드의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090525

Year of fee payment: 15

EXPY Expiration of term